$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000162828017010617 Filed on November 02, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$182.6M	$198.7M	$224.5M
YoY Change	-23.96%	-11.51%	-9.17%
Cost Of Revenue	$112.4M	$132.1M	$162.0M
YoY Change	-33.49%	-18.42%	-11.01%
Gross Profit	$70.19M	$66.56M	$61.72M
YoY Change	-4.88%	7.84%	-5.38%
Gross Profit Margin	38.45%	33.5%	27.49%
Selling, General & Admin	$15.30M	$15.90M	$17.70M
YoY Change	-0.65%	-10.17%	-1.12%
% of Gross Profit	21.8%	23.89%	28.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.400M	$7.100M	$4.200M
YoY Change	-28.89%	69.05%	4.24%
% of Gross Profit	9.12%	10.67%	6.8%
Operating Expenses	$62.70M	$62.30M	$64.50M
YoY Change	3.12%	-3.41%	-1.68%
Operating Profit	$7.494M	$4.263M	-$2.779M
YoY Change	-42.32%	-253.4%	-85.59%
Interest Expense	-$13.40M	-$13.40M	-$9.300M
YoY Change	42.55%	44.09%	-2.11%
% of Operating Profit	-178.81%	-314.33%
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.202M	-$13.00M	-$11.01M
YoY Change	77.21%	18.03%	-61.75%
Income Tax	-$73.20M	$60.00K	$421.0K
% Of Pretax Income
Net Earnings	-$1.962M	-$12.99M	-$11.33M
YoY Change	-84.74%	14.7%	-32.51%
Net Earnings / Revenue	-1.07%	-6.54%	-5.04%
Basic Earnings Per Share
Diluted Earnings Per Share	-$62.70K	-$407.5K	-$393.7K
COMMON SHARES
Basic Shares Outstanding	127.5M shares	127.5M shares	113.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$39.50M	$33.00M	$2.800M
YoY Change	311.46%	1078.57%	-90.48%
Cash & Equivalents	$39.46M	$33.01M	$2.835M
Short-Term Investments
Other Short-Term Assets	$23.60M	$20.20M	$19.50M
YoY Change	27.57%	3.59%	-10.96%
Inventory	$38.04M	$27.78M	$33.38M
Prepaid Expenses
Receivables	$85.52M	$89.20M	$103.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$186.6M	$170.2M	$159.4M
YoY Change	7.65%	6.78%	-20.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$26.97M	$28.73M	$33.71M
YoY Change	-17.46%	-14.78%	-1.16%
Goodwill	$627.4M	$367.2M	$373.1M
YoY Change	71.44%	-1.57%	20.84%
Intangibles	$19.11M
YoY Change	-38.43%
Long-Term Investments
YoY Change
Other Assets	$2.116M	$2.415M	$2.055M
YoY Change	6.33%	17.52%	77.46%
Total Long-Term Assets	$416.5M	$420.1M	$436.0M
YoY Change	-3.51%	-3.66%	20.04%
TOTAL ASSETS
Total Short-Term Assets	$186.6M	$170.2M	$159.4M
Total Long-Term Assets	$416.5M	$420.1M	$436.0M
Total Assets	$603.1M	$590.2M	$595.4M
YoY Change	-0.31%	-0.87%	5.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$65.96M	$42.69M	$45.70M
YoY Change	2.4%	-6.58%	-14.39%
Accrued Expenses	$32.80M	$39.60M	$43.10M
YoY Change	-24.6%	-8.12%	-14.48%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.722M	$1.800M	$48.20M
YoY Change	-90.7%	-96.27%	21.72%
Total Short-Term Liabilities	$105.1M	$89.03M	$140.9M
YoY Change	-19.22%	-36.82%	-4.03%
LONG-TERM LIABILITIES
Long-Term Debt	$478.9M	$476.8M	$388.1M
YoY Change	10.5%	22.85%	-5.18%
Other Long-Term Liabilities	$21.77M	$18.88M	$4.502M
YoY Change	2753.08%	319.35%	-33.73%
Total Long-Term Liabilities	$21.77M	$18.88M	$4.502M
YoY Change	2753.08%	319.35%	-33.73%
TOTAL LIABILITIES
Total Short-Term Liabilities	$105.1M	$89.03M	$140.9M
Total Long-Term Liabilities	$21.77M	$18.88M	$4.502M
Total Liabilities	$605.8M	$588.8M	$550.1M
YoY Change	6.91%	7.05%	-2.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$709.5M	-$704.6M	-$630.9M
YoY Change	9.95%	11.67%	8.14%
Common Stock	$624.8M	$626.6M	$606.7M
YoY Change	2.14%	3.28%	13.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$16.00K	$16.00K	$0.00
YoY Change			-100.0%
Treasury Stock Shares	5.106K shares	5.106K shares	0.000 shares
Shareholders Equity	$606.1M	-$78.00M	-$24.28M
YoY Change
Total Liabilities & Shareholders Equity	$603.1M	$590.2M	$595.4M
YoY Change	-0.31%	-0.87%	5.82%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$1.962M	-$12.99M	-$11.33M
YoY Change	-84.74%	14.7%	-32.51%
Depreciation, Depletion And Amortization	$6.400M	$7.100M	$4.200M
YoY Change	-28.89%	69.05%	4.24%
Cash From Operating Activities	$8.600M	-$4.400M	-$16.90M
YoY Change	-315.0%	-73.96%	-17.16%
INVESTING ACTIVITIES
Capital Expenditures	-$2.100M	-$2.300M	-$2.500M
YoY Change	10.53%	-8.0%	-41.86%
Acquisitions
YoY Change
Other Investing Activities	$0.00		-$64.40M
YoY Change			-387.5%
Cash From Investing Activities	-$2.100M	-$2.300M	-$67.10M
YoY Change	16.67%	-96.57%	-472.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-900.0K	35.40M
YoY Change	-100.8%	-102.54%	15.31%
NET CHANGE
Cash From Operating Activities	8.600M	-4.400M	-16.90M
Cash From Investing Activities	-2.100M	-2.300M	-67.10M
Cash From Financing Activities	-100.0K	-900.0K	35.40M
Net Change In Cash	6.400M	-7.600M	-48.60M
YoY Change	-4.48%	-84.36%	-271.73%
FREE CASH FLOW
Cash From Operating Activities	$8.600M	-$4.400M	-$16.90M
Capital Expenditures	-$2.100M	-$2.300M	-$2.500M
Free Cash Flow	$10.70M	-$2.100M	-$14.40M
YoY Change	-609.52%	-85.42%	-10.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	42191000	USD
CY2017Q3	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	36419000	USD
CY2016Q3	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	2368000	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	3954000	USD
	bios	Gain Losson Dispositionof Property Plant Equipment1 GainLossonDispositionofPropertyPlantEquipment1	-652000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	461000	USD
	bios	Increase Decreasein Amounts Due To Plan Sponsor IncreaseDecreaseinAmountsDueToPlanSponsor	1091000	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	4597000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	9326000	USD
CY2017Q3	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	4037000	USD
	bios	Acquisition Integration Restructuringand Other Expenses AcquisitionIntegrationRestructuringandOtherExpenses	11171000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	4612000	USD
CY2016Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	3799000	USD
CY2017Q3	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	4890000	USD
CY2017Q3	bios	Debt And Warrants Outstanding DebtAndWarrantsOutstanding	497464000	USD
CY2016Q3	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	0	USD
	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	0	USD
CY2017Q3	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	925000	USD
	bios	Effective Income Tax Rate Reconciliation Alternative Minimum Tax Receivable Amount EffectiveIncomeTaxRateReconciliationAlternativeMinimumTaxReceivableAmount	925000	USD
CY2016Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	4699000	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	4597000	USD
CY2017Q3	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
	bios	Gain Losson Changein Fair Valueof Contingent Consideration GainLossonChangeinFairValueofContingentConsideration	0	USD
	bios	Increase Decreasein Fair Valueof Contingent Consideration IncreaseDecreaseinFairValueofContingentConsideration	0	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	127515573	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	59134000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	42691000	USD
CY2016Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	156541000	USD
CY2017Q3	us-gaap	Accounts Receivable Gross AccountsReceivableGross	136035000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	111811000	USD
CY2017Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	89215000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	611844000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	626567000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44730000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	46820000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	44730000	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	46820000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3005000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4166000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	12956000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6552000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20329000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	14000000	shares
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1825000	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-925000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	15500000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16200000	shares
CY2016Q4	us-gaap	Assets Assets	607740000	USD
CY2017Q3	us-gaap	Assets Assets	590248000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	176052000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	170175000	USD
CY2016Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	4695000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	7619000	USD
CY2017Q3	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	246000	USD
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	528000	USD
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15577000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2835000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9569000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33013000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-12742000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	23444000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6088000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-6553000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	117682543	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127520628	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	117682543	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127520628	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	12000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	13000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	161957000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	504485000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	131516000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	433538000	USD
CY2016Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-925000	USD
CY2016Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	118000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	143000	USD
CY2017Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-547000	USD
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-397000	USD
CY2016Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	118000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	143000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	134000	USD
CY2017Q3	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	378000	USD
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	528000	USD
CY2016Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	268000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	393000	USD
CY2017Q3	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	515000	USD
	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1523000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	12452000	USD
CY2017Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4137000	USD
CY2016Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	303000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	450000	USD
CY2017Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	607000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1794000	USD
CY2016Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	35000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	57000	USD
CY2017Q3	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	92000	USD
	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	271000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	2281000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Gross Noncurrent DeferredTaxLiabilitiesGrossNoncurrent	4150000	USD
	us-gaap	Depreciation Depreciation	12956000	USD
	us-gaap	Depreciation Depreciation	20329000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.42
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.12
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.56
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31043000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21734000	USD
CY2016Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3015000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	3954000	USD
CY2017Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	33000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-652000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-13453000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9948000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30413000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9784000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29287000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	365947000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	367198000	USD
CY2016Q3	us-gaap	Gross Profit GrossProfit	62585000	USD
	us-gaap	Gross Profit GrossProfit	190981000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	67176000	USD
	us-gaap	Gross Profit GrossProfit	201070000	USD
CY2016Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	224542000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	695466000	USD
CY2017Q3	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	198692000	USD
	us-gaap	Health Care Organization Revenue HealthCareOrganizationRevenue	634608000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-11090000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-29169000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-12404000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-60090000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-10669000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-28576000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-12344000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-58693000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.12
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.42
CY2017Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.12
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.55
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-174000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	134000	USD
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-113000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-1053000	USD
CY2016Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
CY2017Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.01
CY2016Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1080000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1080000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	421000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	593000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	60000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1397000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4967000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	10282000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4876000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	22194000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-3730000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10002000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4307000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-20543000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-947000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	179000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	38000	USD
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	143000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	131000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	378000	USD
	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	528000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	260000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	327000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-31248000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-17292000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-536000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-4629000	USD
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	0	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1869000	USD
CY2016Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-9331000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-28212000	USD
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-3507000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12802000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6997000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-7841000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-739000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-9161000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3033000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-6720000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-22596000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	4950000	USD
CY2017Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-13175000	USD
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-38635000	USD
	us-gaap	Interest Paid Net InterestPaidNet	30128000	USD
	us-gaap	Interest Paid Net InterestPaidNet	38454000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	6705000	USD
CY2017Q3	us-gaap	Interest Payable Current InterestPayableCurrent	3198000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	36165000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	27775000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	567301000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	588808000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	607740000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	590248000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	130350000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	89026000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	433413000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	476753000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	18521000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1828000	USD
CY2016Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	451934000	USD
CY2017Q3	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	478581000	USD
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	0	USD
	us-gaap	Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments	-1080000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	97179000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44335000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-71383000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9995000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38538000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-10896000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-32450000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4343000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-11264000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-29035000	USD
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18507000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15222000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-12517000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-61143000	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13575000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35745000	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-15086000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-68579000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued1 NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1	3750000	shares
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2163000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2415000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1257000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18879000	USD
CY2016Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	42729000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	123006000	USD
CY2017Q3	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	38325000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	125169000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	980000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	67516000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8044000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5045000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	23060000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	83267000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20776000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	294446000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	84000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	563000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-152000	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-105000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4177000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	32535000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19987000	USD
CY2016Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	111811000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28726000	USD
CY2016Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7727000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19598000	USD
CY2017Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6600000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3347000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1573000	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	3791000	USD
	us-gaap	Restructuring Charges RestructuringCharges	10643000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-643419000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-704562000	USD
CY2017Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	89215000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	525000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	792000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	60000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	55863000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	9411000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	236770000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	2372000	USD
	us-gaap	Restructuring Charges RestructuringCharges	6304000	USD
	us-gaap	Stock Issued1 StockIssued1	9938	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	-31563000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	-77998000	USD
CY2016Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	173000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	518000	USD
CY2017Q3	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	175000	USD
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	525000	USD
CY2016Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2138000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	6192000	USD
CY2017Q3	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	2394000	USD
	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	6911000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	5106	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	16000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	114826000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	85701000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	127488000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	122519000	shares

Files In Submission

Name	View Source	Status
0001628280-17-010617-index-headers.html	Edgar Link	pending
0001628280-17-010617-index.html	Edgar Link	pending
0001628280-17-010617.txt	Edgar Link	pending
0001628280-17-010617-xbrl.zip	Edgar Link	pending
bios-20170930.xml	Edgar Link	completed
bios-20170930.xsd	Edgar Link	pending
bios-20170930x10q.htm	Edgar Link	pending
bios-20170930_cal.xml	Edgar Link	unprocessable
bios-20170930_def.xml	Edgar Link	unprocessable
bios-20170930_lab.xml	Edgar Link	unprocessable
bios-20170930_pre.xml	Edgar Link	unprocessable
bios-ex311x20170930x10q.htm	Edgar Link	pending
bios-ex312x20170930x10q.htm	Edgar Link	pending
bios-ex321x20170930x10q.htm	Edgar Link	pending
bios-ex322x20170930x10q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
logowithregisteredtm07.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2017 Q4 Form 10-Q Financial Statement

#000162828017010617 Filed on November 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2017 Q4 Form 10-Q Financial Statement

#000162828017010617 Filed on November 02, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch